Pyramidal and extrapyramidal involvement in experimental infection of cynomolgus monkeys with enterovirus 71.
about
Experimental primates and non-human primate (NHP) models of human diseases in China: current status and progressA clinically authentic mouse model of enterovirus 71 (EV-A71)-induced neurogenic pulmonary oedema.A Strain-Specific Epitope of Enterovirus 71 Identified by Cryo-Electron Microscopy of the Complex with Fab from Neutralizing AntibodyThe Suramin Derivative NF449 Interacts with the 5-fold Vertex of the Enterovirus A71 Capsid to Prevent Virus Attachment to PSGL-1 and Heparan SulfateDevelopment of a reverse transcription-loop-mediated isothermal amplification (RT-LAMP) system for a highly sensitive detection of enterovirus in the stool samples of acute flaccid paralysis cases.Animal models of enterovirus 71 infection: applications and limitations.The cross-reactivity of the enterovirus 71 to human brain tissue and identification of the cross-reactivity related fragments.Tyrosine sulfation of the amino terminus of PSGL-1 is critical for enterovirus 71 infection.Development of a particle agglutination method with soluble virus receptor for identification of poliovirus.The approved pediatric drug suramin identified as a clinical candidate for the treatment of EV71 infection-suramin inhibits EV71 infection in vitro and in vivoIdentification of site-specific adaptations conferring increased neural cell tropism during human enterovirus 71 infectionEnterovirus 71-induced neurological disorders in young gerbils, Meriones unguiculatus: development and application of a neurological disease model.Enterovirus 71-induced autophagy increases viral replication and pathogenesis in a suckling mouse model.LC16m8, a highly attenuated vaccinia virus vaccine lacking expression of the membrane protein B5R, protects monkeys from monkeypoxGlobal transcriptomic analysis of human neuroblastoma cells in response to enterovirus type 71 infectionAdaptive mutations in the genomes of enterovirus 71 strains following infection of mouse cells expressing human P-selectin glycoprotein ligand-1.Enterovirus 71 binding to PSGL-1 on leukocytes: VP1-145 acts as a molecular switch to control receptor interactionThe Role of VP1 Amino Acid Residue 145 of Enterovirus 71 in Viral Fitness and Pathogenesis in a Cynomolgus Monkey ModelA mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection.Distribution of enteroviruses in hospitalized children with hand, foot and mouth disease and relationship between pathogens and nervous system complications.A Consistent Orally-Infected Hamster Model for Enterovirus A71 Encephalomyelitis Demonstrates Squamous Lesions in the Paws, Skin and Oral Cavity Reminiscent of Hand-Foot-and-Mouth Disease.An attenuated strain of enterovirus 71 belonging to genotype a showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys.Retrograde axonal transport: a major transmission route of enterovirus 71 in mice.Clinical manifestations of severe enterovirus 71 infection and early assessment in a Southern China population.Cooperative effect of the attenuation determinants derived from poliovirus sabin 1 strain is essential for attenuation of enterovirus 71 in the NOD/SCID mouse infection model.Quantification of the dynamics of enterovirus 71 infection by experimental-mathematical investigationStrategies to develop antivirals against enterovirus 71Genomic and immunologic factors associated with viral pathogenesis in a lethal EV71 infected neonatal mouse modelNecrotizing myositis causes restrictive hypoventilation in a mouse model for human enterovirus 71 infectionCooperative effect of the VP1 amino acids 98E, 145A and 169F in the productive infection of mouse cell lines by enterovirus 71 (BS strain).Transgenic mouse model for the study of enterovirus 71 neuropathogenesis.EV71-infected CD14(+) cells modulate the immune activity of T lymphocytes in rhesus monkeys.Scavenger receptor b2 as a receptor for hand, foot, and mouth disease and severe neurological diseases.Progress on the research and development of human enterovirus 71 (EV71) vaccines.Understanding Enterovirus 71 Neuropathogenesis and Its Impact on Other Neurotropic Enteroviruses.Functional comparison of SCARB2 and PSGL1 as receptors for enterovirus 71.Identification of a human SCARB2 region that is important for enterovirus 71 binding and infection.Establishment of a panel of in-house polyclonal antibodies for the diagnosis of enterovirus infections.Preclinical evaluation of the immunogenicity and safety of an inactivated enterovirus 71 candidate vaccine.The distribution of inflammation and virus in human enterovirus 71 encephalomyelitis suggests possible viral spread by neural pathways.
P2860
Q26860345-D060C0EC-5F42-4487-9BA1-311C5B7C95B5Q27334321-6B7305D7-4279-4A47-96EE-329704D15635Q27679681-21509E78-389A-4504-B701-152FCD8F1383Q28550039-15C7A2EA-1D32-43C0-9286-BBCA0E3C8A9BQ33518940-3A207B9A-2613-4C13-9F36-892F12E11F9CQ33579809-BF2BF866-4A6F-427F-A849-7E43B1F7B967Q33732200-C4438554-B8B4-42FB-90CE-0C11170A218BQ33747574-DACA1FBF-F86D-4A21-930A-6E6638D75F1AQ34046404-04409AE3-2A7B-4DFD-A0D7-BBC2E4444173Q34289956-93F4F630-AB2B-42C0-BBE8-42AEECBA03A0Q34387141-836BD0D4-98FD-486C-B780-94A190FFD9F2Q34532705-F702A10D-7278-4932-A7F9-B3300EF71A4CQ34544363-BCA0319F-6709-421F-A7EB-B0132AEB8373Q34648311-670F1662-49CB-49B6-B27C-6DBC8FEE7130Q34825259-ADCAD298-E7BE-474B-AADC-B9A5525120BFQ34837231-130826B3-E072-4CCD-8A64-7E86F395A3CDQ34916727-FF4B8D8D-D1E2-4FBD-8195-8BC8B7BF9210Q35693536-C81F1411-95AA-4022-9E58-364BDEBFB1C3Q35702513-6519C4C4-FA14-4E79-862B-7F917CBBD52CQ35712094-134AC370-E1BD-4ED6-9DAA-EA306397209EQ35905668-E72636A6-045D-4B41-BD3B-12C7BA62F0B9Q35948053-3B837B8E-2412-4435-865C-5C807A08E403Q35948100-1523F1DF-F11B-4C1C-AF87-377BDCB794E4Q36284363-0CEB2565-55F0-4F3C-867D-278195BB606BQ36483299-FC3BF108-66F3-4FA2-B957-85BDC5E5BFAFQ36506787-98CF6472-EC30-4933-843A-3FA7D21FC4CEQ36734771-0F8126C5-16B3-4CDA-B97D-0B433B186A6AQ36817470-B4677A20-F8B7-4A62-89CA-E9FE2CFBBDA5Q37008702-C49E5C05-B797-43B8-A1AA-AC00354B463EQ37064293-35873C7E-CFCD-44E0-83E5-51E77ED76AEFQ37157420-82FCCFD1-CEF7-4AFF-AEA4-4517E31B0CF2Q37289553-C5AC9803-0F2D-4A9F-9C84-63E81D1DBCABQ37987923-9F339B40-ED48-4B54-821F-15C9FB3EFEEFQ38068107-8803667E-0200-4673-9420-181CEE1D3777Q38567118-B33AFD5E-3C07-4BC2-84B6-2461AA5F9E12Q39213405-1CDF36BC-F3C7-419E-990C-D5A7D259E0A9Q39578725-E87CDB78-AC90-40F5-9661-396D6419C382Q41723927-0D54F019-2C43-4B5F-BCED-0587C322E80AQ42254889-F673BA75-5271-4549-9510-15E1688CECA6Q42524022-5623ABFF-8CBB-454F-991A-ABEA044BBC0A
P2860
Pyramidal and extrapyramidal involvement in experimental infection of cynomolgus monkeys with enterovirus 71.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Pyramidal and extrapyramidal i ...... s monkeys with enterovirus 71.
@en
Pyramidal and extrapyramidal i ...... s monkeys with enterovirus 71.
@nl
type
label
Pyramidal and extrapyramidal i ...... s monkeys with enterovirus 71.
@en
Pyramidal and extrapyramidal i ...... s monkeys with enterovirus 71.
@nl
prefLabel
Pyramidal and extrapyramidal i ...... s monkeys with enterovirus 71.
@en
Pyramidal and extrapyramidal i ...... s monkeys with enterovirus 71.
@nl
P2093
P2860
P356
P1476
Pyramidal and extrapyramidal i ...... s monkeys with enterovirus 71.
@en
P2093
Ayako Harashima
Hiroyuki Shimizu
Noriyo Nagata
Takuya Iwasaki
Tatsuo Miyamura
Yasushi Ami
Yoshio Tano
Yuriko Suzaki
P2860
P304
P356
10.1002/JMV.2209
P577
2002-06-01T00:00:00Z